Association Between Rocuronium Administration and Clinical Outcomes in Patients With Moderate-To-Severe Acute Respiratory Distress Syndrome: A Retrospective Cohort Study
Continuous rocuronium administration for moderate-to-severe ARDS, specifically in patients with pneumonia, was not associated with either improved or worsened clinical outcomes. These findings suggest that rocuronium may be a feasible option as a supportive therapy for ventilator management in patients with moderate-to-severe ARDS, providing a basis for further research in clinical settings.
Authors
- Mayuko Tonai (ORCID: https://orcid.org/0000-0002-8310-5726)
- Yusuke Sasabuchi (ORCID: https://orcid.org/0000-0001-7828-0549)
- Hiroki Matsui (ORCID: https://orcid.org/0000-0002-1049-7925)
- Hideaki Watanabe (ORCID: https://orcid.org/0000-0002-3925-2665)
- Hideo Yasunaga (ORCID: https://orcid.org/0000-0002-6017-469X)
Institutions
- Kameda Medical Center (JP)
- University of Tokyo Health Sciences (JP)
- The University of Tokyo (JP)
Publication Details
- Journal
- Annals of Pharmacotherapy
- Published
- 2025-03-28
- DOI
- https://doi.org/10.1177/10600280251329195
- Citations
- 1
- Primary Topic
- Respiratory Support and Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- Ministry of Health, Labour and Welfare